Gufic Biosciences soars 14%, hits 52-week high on improved business outlook
Rating agency CRISIL Ratings has revised the company's outlook on the long-term bank facilities12-04-2022
12-04-2022
GUFIC BIOSCIENCES LTD. - 509079 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ami N ShahDesignation :- Company Secretary and Compliance Officer11-04-2022
GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith a press release being issued by the Company on the subject " Gufic receives permission from CDSCO to manufacture and sale Isavuconazonium Sulfate API and Finished formulation Isavuconazole for Injection 200 mg/vial." The same is submitted for public dissemination and your records.11-04-2022
GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith a press release being issued by the Company on the captioned subject, the content of which is self-explanatory. The same is submitted for public dissemination and your records.05-04-2022
GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company's Code of Conduct framed under the said provisions, the Trading Window for dealing in securities of the Company shall remain closed for all the Insiders (including Directors and Connected/ Designated Persons and their immediate relatives)from Friday, April 01, 2022 till 48 hours after the declaration of Audited Financial Results of the Company for the quarter and year ended March 31, 2022. The date of meeting of the Board of Directors to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2022 will be informed in due course. Kindly take the same on record.31-03-2022
GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the Regulation 30(6) read with Part A of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details, enclosed herewith.23-03-2022
GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Outcome for Appointment Of Secretarial Auditor Of The Company For Financial Year 2021-22
Pursuant to the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that inter alia the Board of Directors of the Company at its meeting held today i.e Monday, March 21, 2022 commenced at 5:30 p.m., and concluded at 6:30 p.m., appointed M/s. Manish Ghia & Associates, Practicing Company Secretaries, Mumbai as the Secretarial Auditor of the Company to conduct Secretarial Audit of the Company for the Financial year 2021 -22 and issue report thereon. Further, as per the requirement of the Circular No. CIR/CFD/ CMD/4/2015 dated 9th September, 2015, a copy of brief details of M/s. Manish Ghia & Associates, is attached herewith in Annexure - A for your reference. Kindly take the same on record.21-03-2022
GUFIC BIOSCIENCES LTD. - 509079 - Intimation For Incorporation Of Wholly Owned Subsidiary Company In United Kingdom
In continuance to our letter dated February 09, 2022 and pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has incorporated a Wholly Owned Subsidiary Company namely 'GUFIC UK LIMITED', the details whereof is set out in Annexure 'A'. You are requested to take the same on record16-03-2022
GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith is the press release being issued by the Company on the captioned subject, the content of which is self-explanatory. The same is submitted for public dissemination and your records.09-03-2022
GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
This is in furtherance to our communication dated February 10, 2022 on Earning Conference Call and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on February 10, 2022 at 4: 30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/Transcript%20of%20Q3%20Earning%20Call.pdf Kindly take the same on record.14-02-2022